¼¼°èÀÇ ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ȯÀÚ ¼öº°, ÃÖÁ¾»ç¿ëÀÚº°, ±¹°¡º°, Áö¿ªº° - »ê¾÷ ºÐ¼®, ½ÃÀå ±Ô¸ð ¹× Á¡À¯À², ¿¹Ãø(2025-2032³â)
Centralized Patient Monitoring System Market, By Number of Patients, By End-user, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
»óǰÄÚµå : 1663459
¸®¼­Ä¡»ç : AnalystView Market Insights
¹ßÇàÀÏ : 2025³â 01¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 303 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 3,250 £Ü 4,702,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠺Ұ¡´ÉÇϸç, ÅØ½ºÆ®ÀÇ Copy&Pasteµµ ºÒ°¡´ÉÇÕ´Ï´Ù.
US $ 4,650 £Ü 6,728,000
PDF (5 User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 5¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 5,650 £Ü 8,174,000
PDF & Excel (Enterprise User License) help
PDF & Excel º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ ³» ¸ðµç »ç¿ëÀÚ°¡ »ç¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. ÅØ½ºÆ®ÀÇ Copy&Paste °¡´ÉÇÕ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¸®Æ÷Æ® ÇÏÀ̶óÀÌÆ®

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 6¾ï 1,450¸¸ ´Þ·¯·Î, 2025-2032³â¿¡ CAGR 7.10%·Î È®´ë

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ¿ªÇÐ

ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±

ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±Àº Àü ¼¼°è¿¡¼­ ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ »ç¿ë°ú È¿°ú¸¦ ÃËÁøÇÏ´Â µ¥ ÀÖÀ¸¸ç, ÇʼöÀûÀÔ´Ï´Ù. ÀÇ·á ½Ã¼³¿¡¼­´Â ÀÎÇÁ¶ó Çö´ëÈ­¿Í ÇÔ²² Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ±â´ÉÀ» ±¸ÇöÇϴ ÷´Ü ±â¼ú¿¡ ´ëÇÑ ÅõÀÚ°¡ Ȱ¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. Áø·á°ú¿Í ÀÇ·á ¼­ºñ½º ÇÁ·Î¹ÙÀÌ´õ °£ÀÇ µ¥ÀÌÅÍ È帧À» ¿øÈ°ÇÏ°Ô Çϱâ À§Çؼ­´Â »óÈ£ ¿î¿ë °¡´ÉÇÑ ½Ã½ºÅÛ µµÀÔ, ÀüÀڰǰ­±â·Ï(EHR) ÅëÇÕ, °­·ÂÇÑ IT ÇÁ·¹ÀÓ¿öÅ© ±¸ÃàÀÌ ÇÊ¿äÇÕ´Ï´Ù. ÀÌ·¯ÇÑ °³¼±À» ÅëÇØ ¿©·¯ Àå¼Ò¿¡¼­ ȯÀÚ¸¦ ½Ç½Ã°£À¸·Î ¸ð´ÏÅ͸µÇÏ´Â °ÍÀÌ ¿ëÀÌÇØÁ® ½Å¼ÓÇÑ Ä¡·á¿Í Ä¡·á °á°úÀÇ Çâ»óÀ» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ È¯ÀÚ ÁýÁß ¸ð´ÏÅ͸µ¿¡ ÇÊ¿äÇÑ Ã·´Ü ÀÇ·á±â±â ¹× ¼¾¼­ÀÇ µµÀÔÀº ÀÇ·á ÀÎÇÁ¶óÀÇ °³¼±À¸·Î Áö¿øµÇ°í ÀÖ½À´Ï´Ù. Çö´ëÀÇ º´¿ø°ú ÀÇ·á ½Ã¼³¿¡´Â »ý¸®Àû µ¥ÀÌÅÍ¿Í È°·Â ¡Èĸ¦ ½±°Ô ±â·ÏÇÒ ¼ö ÀÖ´Â ÃÖ÷´Ü ¸ð´ÏÅ͸µ Àåºñ°¡ ÀåÂøµÇ¾î ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¹ßÀüÀº ȯÀÚ µ¥ÀÌÅÍÀÇ Á¤È®¼º°ú ½Å·Ú¼ºÀ» ³ôÀ̰í, ÀÇ·áÁøÀÌ ½Å¼ÓÇÏ°í ´ÜÈ£ÇÑ Á¶Ä¡¸¦ ÃëÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á ȯÀÚ Ä¡·áÀÇ Àü¹ÝÀûÀÎ ¼öÁØÀ» Çâ»ó½Ã۰í ÀÖ½À´Ï´Ù.

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ÁÖ¿ä °í·Á»çÇ×

¸®¼­Ä¡ ¾Ö³Î¸®½ºÆ®ÀÇ ºÐ¼®¿¡ µû¸£¸é ¼¼°è ½ÃÀåÀº ¿¹Ãø ±â°£(2025-2032³â) µ¿¾È ¸Å³â ¾à 7.10%ÀÇ ¿¬Æò±Õ º¹ÇÕ ¼ºÀå·ü(CAGR)·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ȯÀÚ ¼ö ±âÁØÀ¸·Î´Â 16¸í ÀÌÇÏ Ä«Å×°í¸®°¡ 2024³â °¡Àå Å« ½ÃÀå Á¡À¯À²À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøµÇ¾ú½À´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î´Â 2024³â º´¿øÀÌ ÁÖ¿ä ºÎ¹®À¸·Î ²ÅÇû½À´Ï´Ù.

Áö¿ªº°·Î´Â ºÏ¹Ì°¡ 2024³â ¸ÅÃâÀ» âÃâÇÒ ÁÖ¿ä ½ÃÀåÀÔ´Ï´Ù.

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ¼¼ºÐÈ­ ºÐ¼®

¼¼°è ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀº ȯÀÚ ¼ö, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªÀ» ±âÁØÀ¸·Î ¼¼ºÐÈ­µË´Ï´Ù.

ȯÀÚ ¼öº°·Î ½ÃÀåÀº 16¸í ÀÌÇÏ, 17-32¸í, 33-64¸í, 64¸í ÀÌ»óÀ¸·Î ºÐ·ùµÇ¸ç, 2024³â¿¡´Â 16¸í ÀÌÇÏ Ä«Å×°í¸®°¡ ½ÃÀåÀ» ÁÖµµÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, 16¸í ÀÌÇÏ È¯ÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ÁÖ¿ä »ç¿ëÀÚ´Â º´¿ø Àü¹®Ä¡·á½Ç, ¿Ü·¡Áø·á½Ç, ¼Ò±Ô¸ð Áø·á¼ÒÀÔ´Ï´Ù. ¼Ò±Ô¸ð Áø·á¼ÒÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±¸¼ºÀº ÀϹÝÀûÀ¸·Î ¼Ò¼öÀÇ ¿þ¾î·¯ºí ¸ð´ÏÅÍ ¶Ç´Â ħ´ë ¿· ¸ð´ÏÅÍ¿Í ÀÎÅÍÆäÀ̽ºÇÏ´Â ¼ÒÇü Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ½ºÅ×ÀÌ¼Ç ¶Ç´Â ¼ÒÇÁÆ®¿þ¾î Ç÷§ÆûÀÌ »ç¿ëµË´Ï´Ù. ƯÁ¤ ¼öÀÇ È¯ÀÚ¸¦ ´ë»óÀ¸·Î Áö¼ÓÀûÀΠȰ·Â ¡Èĸ¦ ¸ð´ÏÅ͸µÇϰí À§±â ¶Ç´Â ±âŸ Áß´ëÇÑ »ç°ÇÀÌ ¹ß»ýÇÒ °æ¿ì ÀÇ·á Àü¹®°¡¿¡°Ô Àû½Ã¿¡ °æ°íÇÒ ¼ö ÀÖ´Â Áß¿äÇÑ ¸ð´ÏÅ͸µ ±â´ÉÀ» Á¦°øÇÕ´Ï´Ù.

ÃÖÁ¾»ç¿ëÀÚº°·Î ½ÃÀåÀº º´¿ø, ¿Ü»ó ¼¾ÅÍ, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ±âŸ·Î ±¸ºÐµË´Ï´Ù. ÀÌ ½ÃÀå¿¡¼­ º´¿øÀÌ °¡Àå Å« ºÎºÐÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù. º´¿ø¿¡¼­´Â ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» »ç¿ëÇÏ¿© ´Ù¾çÇÑ ºÎ¼­¿Í ºÎ¼­¿¡¼­ ȯÀÚÀÇ ´Ù¾çÇÑ »óŸ¦ ¸ð´ÏÅ͸µÇÕ´Ï´Ù. ÀÌ·¯ÇÑ ½Ã½ºÅÛÀº ÀÀ±Þ½Ç, ÀÏ¹Ý º´µ¿, ÁßȯÀÚ½Ç(ICU), ¼ö¼ú½Ç µî ½Å¼ÓÇÑ °³ÀÔ°ú È¿À²ÀûÀÎ ÀÓ»ó °ü¸®¸¦ À§ÇØ Áö¼ÓÀûÀΠȰ·Â ¡ÈÄ ¹× ȯÀÚ »óÅ ¸ð´ÏÅ͸µÀÌ ÇÊ¿äÇÑ °÷¿¡¼­ ÇʼöÀûÀÔ´Ï´Ù. ÀüÀڰǰ­±â·Ï(EHR), ¿ø°Ý ÃøÁ¤ ½Ã½ºÅÛ, ħ´ë ¿· ¸ð´ÏÅÍ´Â ¸ðµÎ º´¿ø³» Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ½ºÅ×À̼ǰú ÅëÇյǾî ÀÖ½À´Ï´Ù. À̸¦ ÅëÇØ ÀÇ·á Àü¹®°¡´Â ȯÀÚÀÇ µ¿ÇâÀ» ÃßÀûÇϰí, ¿öÅ©Ç÷ο츦 ÃÖÀûÈ­Çϸç, ´õ ³ªÀº ȯÀÚ °á°ú¸¦ À§ÇØ Áø·á Á¶Á¤À» °³¼±ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº° ºÐ¼®

2024³â ºÏ¹Ì´Â °­·ÂÇÑ ÀÇ·á ½Ã½ºÅÛ, ÷´Ü ÀÇ·á ±â¼úÀÇ º¸±Þ, ¾ö°ÝÇÑ ±ÔÁ¦ ȯ°æÀ¸·Î ÀÎÇØ ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¼¼°è ½ÃÀå¿¡¼­ Áö¹èÀûÀÎ À§Ä¡¸¦ Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ³ôÀº ÀÇ·áºñ, ±â¼ú ¹ßÀü, ȯÀÚ ¾ÈÀü ¹× Ä¡·áÀÇ Áú¿¡ ´ëÇÑ Á߿伺ÀÌ ºÏ¹Ì, ƯÈ÷ ¹Ì±¹°ú ij³ª´ÙÀÇ ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀÔ´Ï´Ù. À̵é Áö¿ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» °³¼±Çϰí, ¿öÅ©Ç÷ο츦 °£¼ÒÈ­Çϸç, ȯÀÚ °á°ú¸¦ °³¼±Çϱâ À§ÇØ º´¿ø, ASC, ¿Ü»ó¼¾ÅÍ µî Àü ¼¼°è¿¡¼­ Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ¼Ö·ç¼Ç µµÀÔÀÌ È°¹ßÈ÷ ÀÌ·ç¾îÁö°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ¼Ö·ç¼ÇÀº ÷´Ü ¿ø°Ý ÃøÁ¤ ½Ã½ºÅÛ, ħ´ë ¿· ¸ð´ÏÅÍ, Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ½ºÅ×À̼ÇÀ» ÅëÇÕÇϰí ÀÖ½À´Ï´Ù.

±×·¯³ª ¿¹Ãø ±â°£ Áß ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÀÎÇÁ¶ó ÁöÃâ Áõ°¡, ÀÇ·á ÅõÀÚ Áõ°¡, µðÁöÅÐ Çコ ±â¼ú »ç¿ë Áõ°¡·Î ÀÎÇØ °¡Àå ºü¸¥ CAGRÀ» ³ªÅ¸³¾ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. Áß±¹, Àεµ, ÀϺ» µîÀÇ ±¹°¡µéÀº ÀÇ·á Á¢±Ù¼º°ú ÁúÀ» ³ôÀ̱â À§ÇØ ¿ø°ÝÀÇ·á, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, ½º¸¶Æ® ÀÇ·á ÇÁ·ÎÁ§Æ®¿¡ ÅõÀÚÇϰí ÀÖ½À´Ï´Ù. ½Ç½Ã°£ ȯÀÚ ¸ð´ÏÅ͸µ, µ¥ÀÌÅÍ ºÐ¼® ¹× ¿ø°ÝÀÇ·á ¼­ºñ½º´Â ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Áß¾Ó ÁýÁᫎ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ¿¡ ÀÇÇØ Áö¿øµÇ¸ç, ¿ø°Å¸® Áø·á¼ÒºÎÅÍ µµ½Ã º´¿ø±îÁö ´Ù¾çÇÑ ÀÇ·á ¿ä±¸ »çÇ׿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ±â¼ú ÅëÇÕ°ú ÀÇ·á Çõ½Å¿¡ ÁßÁ¡À» µÐ ÀÌ Áö¿ªÀº ½ÃÀå ÁøÃâ±â¾÷¿¡°Ô µµ´Þ ¹üÀ§¸¦ ³ÐÈ÷°í º¯È­ÇÏ´Â ÀÇ·á ¹®Á¦¸¦ ÇØ°áÇϱâ À§ÇØ ³ë·ÂÇÏ´Â ±â¾÷¿¡°Ô Å« ¼ºÀå Àü¸ÁÀ» Á¦°øÇÕ´Ï´Ù.

ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : °æÀï ±¸µµ

°æÀïÀÌ Ä¡¿­ÇÑ ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ »ê¾÷¿¡´Â ¼ö¸¹Àº Áß¿äÇÑ °æÀï¾÷ü°¡ Á¸ÀçÇÕ´Ï´Ù. ½ÃÀå ÁöÀ§¸¦ Çâ»ó½Ã۱â À§ÇØ ¾÷°è ±â¾÷Àº ¿¬±¸°³¹ß, Á¦Ç° Ãâ½Ã, Àü·«Àû Á¦ÈÞ, M&A¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷À¸·Î´Â Philips ÇコÄɾî, Koninklijke Philips N.V., Infinium Medical, Universal Medical Instruments, GE Healthcare µîÀÌ ÀÖ½À´Ï´Ù. ¼ÒºñÀÚ ¹× ÀÇ·á ¼ö¿ä Áõ°¡¿¡ ´ëÀÀÇϱâ À§ÇØ ÀÌµé ¾÷°è Âü¿©ÀÚµéÀº Áö¼ÓÀûÀ¸·Î ÅõÀÚ¿Í Çõ½ÅÀ» Ãß±¸Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î 2023³â 5¿ù ¹Ì±¹ ½ÄǰÀǾ౹(FDA)Àº AbbottÀÇ »ðÀÔÇü ½ÉÀå ¸ð´ÏÅÍ(ICM) Assert-IQTM¸¦ ½ÂÀÎÇÏ¿© ºÎÁ¤¸Æ ȯÀÚ¿¡°Ô Àå±â ¸ð´ÏÅ͸µ ¹× Áø´Ü Æò°¡¸¦ À§ÇÑ »õ·Î¿î ¿É¼ÇÀ» Á¦°øÇß½À´Ï´Ù. À̹ø ½ÂÀÎÀ¸·Î Àǻ簡 ȯÀÚ¸¦ ¿ø°ÝÀ¸·Î °ü¸®Çϰí Ä¡·áÇÒ ¼ö ÀÖµµ·Ï Áö¿øÇÏ´Â AbbottÀÇ ¿¬µ¿Çü ÀÇ·á±â±â ¶óÀξ÷À» È®ÀåÇÏ°Ô µÇ¾ú½À´Ï´Ù.

ÃÖ±Ù µ¿Çâ

2024³â 11¿ù FDA´Â GEÇコÄɾîÀÇ Novii »ê¸ð-ÅÂ¾Æ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀ» 34ÁÖ ÀÌ»óÀÇ ÀÓ»êºÎ¿¡°Ô È®´ë »ç¿ëÇϵµ·Ï ½ÂÀÎÇßÀ¸¸ç, Novii´Â Àڱà Ȱµ¿, »ê¸ðÀÇ ½É¹Ú¼ö, žÆÀÇ ½É¹Ú¼ö¸¦ ºñħ½ÀÀûÀ¸·Î ÃøÁ¤Çϰí Ç¥½ÃÇÏ¿© ÀÔ¿ø ÁßÀΠȯÀÚ¿¡°Ô Æí¾ÈÇÔ°ú À̵¿¼ºÀ» Á¦°øÇÕ´Ï´Ù.

2023³â 1¿ù Senet°ú Telli Health´Â ÃÖÃÊÀÇ LoRaWAN Áö¿ø ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ(RPM) Àåºñ¸¦ ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ±â¼úÀº ÀÇ·áÁøÀÌ ¿øÁֹΠĿ¹Â´ÏƼ¿Í °°Àº ¼Ò¿ÜµÈ Áö¿ªÀÇ È¯ÀÚµé°ú ´õ ¸¹ÀÌ Á¢ÃËÇÒ ¼ö ÀÖµµ·Ï ÇÔÀ¸·Î½á ÀÇ·áÀÇ ÇüÆò¼º°ú Æ÷°ý¼ºÀ» Çâ»ó½ÃŰ°í ¹Ì·¡ÀÇ ½º¸¶Æ®È¨ ¼­ºñ½ºÀÇ Åä´ë¸¦ ¸¶·ÃÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå °³¿ä

Á¦2Àå °³¿ä

Á¦3Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛÀÇ ÁÖ¿ä ½ÃÀå µ¿Çâ

Á¦4Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : »ê¾÷ ºÐ¼®

Á¦5Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : COVID-19ÀÇ ¿µÇ⠺м®

Á¦6Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå ±¸µµ

Á¦7Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ȯÀÚ ¼öº°

Á¦8Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

Á¦9Àå ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ½ÃÀå : Áö¿ªº°

Á¦10Àå ÁÖ¿ä º¥´õ ºÐ¼® : ÁýÁßÇü ȯÀÚ ¸ð´ÏÅ͸µ ½Ã½ºÅÛ ¾÷°è

Á¦11Àå AnalystViewÀÇ Àü¹æÀ§Àû ºÐ¼®

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

REPORT HIGHLIGHT

Centralized Patient Monitoring System Market size was valued at US$ 614.5 Million in 2024, expanding at a CAGR of 7.10% from 2025 to 2032.

Centralized patient monitoring systems are made up of a network of interconnected medical equipment and software that make it possible to continuously monitor and gather vital signs and other pertinent information from patients. Healthcare professionals can access real-time patient data using these technologies, identify important changes, and make prompt therapeutic decisions. Healthcare providers can increase productivity, monitor more patients at once, and improve patient outcomes by centralizing patient data. The growing demand for remote patient monitoring, improvements in medical technology, and an increased emphasis on enhancing patient outcomes are all driving the market for centralized patient monitoring systems. Among the many advantages of centralized patient monitoring systems are ongoing patient observation, early anomaly identification, and prompt intervention. However, obstacles like interoperability problems, data security concerns, and the demand for qualified healthcare workers could impede the centralized patient monitoring systems industry expansion. Nevertheless, the market offers chances for manufacturers, healthcare providers, and tech developers to create cutting-edge centralized patient monitoring systems and revolutionize the way healthcare is delivered.

Centralized Patient Monitoring System Market- Market Dynamics

Improved Healthcare Infrastructure

Globally, improved healthcare infrastructure is essential to promoting the use and effectiveness of centralized patient monitoring systems. Healthcare facilities frequently make investments in cutting-edge technologies that enable centralized monitoring capabilities as they modernize their infrastructure. In order to facilitate data flow between departments and healthcare providers, this entails putting in place interoperable systems, integrating electronic health records (EHRs), and building strong IT frameworks. These improvements make it easier to monitor patients in real-time across several locations, guaranteeing prompt treatments and improved therapeutic results. Additionally, the deployment of advanced medical equipment and sensors required for centralized patient monitoring is supported by improved healthcare infrastructure. Modern hospitals and healthcare facilities are increasingly outfitted with cutting-edge monitoring devices that can easily record physiological data and vital signs. These developments improve patient data's accuracy and dependability while also empowering medical personnel to act quickly and decisively, which raises the standard of patient care overall.

Centralized Patient Monitoring System Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 7.10% over the forecast period (2025-2032)

Based on the number of patients segmentation, the <16 number of patients category was predicted to show the maximum market share in the year 2024

Based on end use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Centralized Patient Monitoring System Market- Segmentation Analysis:

The Global Centralized Patient Monitoring System Market is segmented on the basis of Number of Patients, End-user, and Region.

On the basis of number of patients, the market is segregated into <16 number of patients, 17-32 number of patients, 33-64 number of patients, and >64 number of patients. In 2024, the market was dominated by the <16 number of patients category. Hospital-specialized care units, outpatient departments, and tiny clinics are the main users of systems made for monitoring fewer than 16 patients. These configurations usually make use of small, centralized monitoring stations or software platforms that interface with a small number of wearables or bedside monitors. For a specific number of patients, they offer crucial monitoring capabilities that guarantee ongoing vital sign surveillance and timely alerting of medical professionals in the event of crises or other significant occurrences.

Based on end-user, the market is divided into Hospitals, Trauma Centers, Ambulatory Surgical centers, and Others. In this market, hospitals make up the largest segment. They use centralized patient monitoring systems to monitor a variety of patient statuses in different departments and units. These systems are essential in emergency rooms, general wards, intensive care units (ICUs), and operating theatres where ongoing vital signs and patient status monitoring are necessary for prompt intervention and efficient clinical management. Electronic health records (EHRs), telemetry systems, and bedside monitors are all integrated with centralized monitoring stations in hospitals. This allows medical professionals to track patient trends, optimize workflow, and improve care coordination for better patient outcomes.

Centralized Patient Monitoring System Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Centralized Patient Monitoring Systems, distinguished by strong healthcare systems, widespread use of cutting-edge medical technology, and strict regulatory environments. High healthcare costs, technology advancements, and a focus on patient safety and care quality are the main factors driving the market for centralized patient monitoring systems in North America, especially in the US and Canada. In order to improve clinical decision-making, streamline workflow, and enhance patient outcomes, these regions are at the forefront of the adoption of centralized monitoring solutions across hospitals, ASCs, and trauma centres. These solutions integrate advanced telemetry systems, bedside monitors, and centralized monitoring stations.

However, throughout the projected period, the Asia-Pacific region is anticipated to see the fastest CAGR driven by growing infrastructure spending, increased investments in healthcare, and the growing use of digital health technologies. To increase access to and the quality of healthcare, nations like China, India, and Japan are investing in telemedicine, remote patient monitoring, and smart healthcare projects. Real-time patient monitoring, data analytics, and telemedicine services are supported by centralized monitoring systems in Asia Pacific, which serve a range of healthcare requirements from distant clinics to urban hospitals. The region's emphasis on technology integration and healthcare innovation offers significant growth prospects for market participants looking to broaden their reach and tackle changing healthcare issues.

Centralized Patient Monitoring System Market- Competitive Landscape:

There are a number of important competitors in the fiercely competitive centralized patient monitoring system industry. To improve their market position, companies in the industry concentrate on R&D, product launches, strategic alliances, and mergers and acquisitions. Among the leading companies in the market for centralized patient monitoring systems are Philips Healthcare, Koninklijke Philips N.V., Infinium Medical, Universal Medical Instruments, and GE Healthcare, among others. In order to meet the growing demands of consumers and healthcare, these industry participants are also always looking for investments and innovations. For instance, in May 2023, the U.S. Food and Drug Administration (FDA) approved Abbott's Assert-IQTM insertable cardiac monitor (ICM), providing patients with irregular heartbeats with a new alternative for long-term monitoring and diagnostic evaluation. With this approval, Abbott's line of linked medical devices that can assist physicians in remotely managing and treating patients is expanded.

Recent Development

November 2024: The FDA has approved GE HealthCare's expanded use of the Novii+ maternal and fetal monitoring system for expectant mothers who are 34 weeks or more along. Novii+ gives patients comfort and mobility in the hospital by noninvasively measuring and displaying uterine activity, maternal heart rate, and fetal heart rate.

January 2023: Senet and Telli Health introduced the first LoRaWAN-enabled remote patient monitoring (RPM) devices. By enabling healthcare practitioners to contact more patients in underserved and remote places, such as indigenous communities, this technology will improve healthcare fairness and inclusivity and lay the groundwork for future smart home services.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY NUMBER OF PATIENTS- MARKET ANALYSIS, 2019 - 2032

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY END-USER- MARKET ANALYSIS, 2019 - 2032

GLOBAL CENTRALIZED PATIENT MONITORING SYSTEM MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

Table of Contents

1. Centralized Patient Monitoring System Market Overview

2. Executive Summary

3. Centralized Patient Monitoring System Key Market Trends

4. Centralized Patient Monitoring System Industry Study

5. Centralized Patient Monitoring System Market: COVID-19 Impact Analysis

6. Centralized Patient Monitoring System Market Landscape

7. Centralized Patient Monitoring System Market - By Number of Patients

8. Centralized Patient Monitoring System Market - By End-user

9. Centralized Patient Monitoring System Market- By Geography

10. Key Vendor Analysis- Centralized Patient Monitoring System Industry

11. 360 Degree Analyst View

12. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â